Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Combination Therapy With Cystagon and N-Acetylcysteine for INCL Patients
NCT00028262Phase 4Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Feb 2001
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cysteamine, acetylcysteine in infantile neuronal ceroid lipofuscinosis (INCL), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Feb 2001; status: completed.
02
Drugs
cysteamineacetylcysteine
03
Conditions
infantile neuronal ceroid lipofuscinosis (INCL)
Beyond the preview
Go deeper on NCT00028262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028262.